| Cerebrotendineous xanthomatosis | |
| Classification and external resources | |
| ICD-10 | E75.5 |
|---|---|
| ICD-9 | 272.7 |
| OMIM | 213700 |
| DiseasesDB | 29239 |
| eMedicine | / |
| MeSH | [1] |
Cerebrotendineous xanthomatosis (or cerebrotendinous xanthomatosis, with one fewer 'e', or cerebrotendinous cholesterosis) is a form of xanthomatosis.[1]:535
Contents |
Causes
It is autosomal recessive,[2] and associated with the CYP27A1 gene on chromosome 2.
Presentation
An inherited disorder associated with the deposition of a form of cholesterol in the brain and other tissues and with elevated levels of cholesterol in plasma but with normal total cholesterol level; it is characterized by progressive cerebellar ataxia beginning after puberty and by juvenile cataracts, and tendineous or tuberous xanthomas.
Eponym
It is also known as "Van Bogaert-Scherer-Epstein syndrome".[3][4]
See also
References
- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ^ Pilo de la Fuente B, Ruiz I, Lopez de Munain A, Jimenez-Escrig A (May 2008). "Cerebrotendinous xanthomatosis: Neuropathological findings". J. Neurol. 255: 839. doi:. PMID 18458861.
- ^ synd/1452 at Who Named It?
- ^ L. van Bogaert, H. J. Scherer, E. Epstein. Une forme cérébrale de la cholestérinose généralisée (type particulier de lipidose à cholestérine). Paris, Masson, 1937.
|
||||||||||||||||||||||||||||
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
